Effects of histamine H3 receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeys

Pharmacology

Volumn 83, Issue 3, 2009, Pages 164-169

  Banks, Matthew L ^a   Manvich, Daniel F ^a   Bauzo, Rayna M ^a   Howell, Leonard L ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Fixed interval schedule, monkeys; Histamine H3 receptor; Locomotor behavior, mice; Methamphetamine

Indexed keywords

COCAINE; HISTAMINE H3 RECEPTOR; IMETIT; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUIRREL MONKEY; STIMULUS RESPONSE;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HISTAMINE AGONISTS; IMIDAZOLES; MALE; METHAMPHETAMINE; MICE; MOTOR ACTIVITY; RECEPTORS, HISTAMINE H3; REINFORCEMENT SCHEDULE; SAIMIRI; THIOUREA;

EID: 58149475802     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000191473     Document Type: Article

References (25)

1. Itoh K, Fukumori R, Suzuki Y: Effect of methamphetamine on the locomotor activity in the 6-OHDA dorsal hippocampus lesioned rat. Life Sci 1984;34:827-833.
2. Di Chiara G, Imperato A: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988;85:5274-5278.
3. Czoty PW, Ginsburg BC, Howell LL: Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 2002;300:831-837.
4. Passani MB, Lin JS, Hancock A, Crochet S, Blandina P: The histamine H 3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci 2004;25:618-625.
5. Haas H, Panula P: The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 2003;4:121-130.
6. Arrang JM, Roy J, Morgat JL, Schunack W, Schwartz JC: Histamine H 3 receptor binding sites in rat brain membranes: modulations by guanine nucleotides and divalent cations. Eur J Pharmacol 1990;188:219-227.
7. 3) visualized in the brain of human and non-human primates. Brain Res 1990;526:322-327.
8. 125I]iodophenpropit. Naunyn Schmiedebergs Arch Pharmacol 2000;362:60-67.
9. 3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release. Neuropsychopharmcology 2004;29:705-717.
10. 3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse. Eur J Pharmacol 1994;259:107-114.
11. 3 receptor. J Pharmacol Exp Ther 2002;300:621-628.
12. 3 receptor antagonist. J Pharmacol Exp Ther 2005;313:176-190.
13. 3-receptor antagonist thioperamide potentiates behavioural effects of cocaine. Eur J Pharm Sci 2003;19:S25.
14. Brabant C, Quertemont E, Tirelli E: Effects of the H 3 -receptor inverse agonist thioperamide on the psychomotor effects induced by acutely and repeatedly given cocaine in C57BL/6J mice. Pharmacol Biochem Behav 2006;83:561-569.
15. Kimmel HL, O'Connor JA, Carrol FI, Howell LL: Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys. Pharmacol Biochem Behav 2007;86:45-54.
16. Yarosh HL, Katz EB, Coop A, Fantegrossi WE: MDMA-like behavioral effects of N-substituted piperazines in the mouse. Pharmacol Biochem Behav 2007;88:18-27.
17. 2 receptors and the implications for striatal function. Neuropharmacology 2008;55:190-197.
18. Krueger KM, Witte DG, Ireland-Denny L, Miller TR, Baranowski JL, Buckner S, Milicic I, Esbenshade TA, Hancock AA: G protein-dependent pharmacology of histamine H 3 receptor ligands: evidence for heterogeneous active state receptor conformations. J Pharmacol Exp Ther 2005;314:271-281.
19. Ito C, Onodera K, Sakurai E, Sato M, Watanabe T: Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine. J Pharmacol Exp Ther 1996;279:271-276.
20. Ito C, Onodera K, Yamatodani A, Watanabe T, Sato M: The effect of methamphetamine on histamine release in the rat hypothalamus. Psychiatry Clin Neurosci 1997;51:79-81.
21. Ishizuka T, Murakami M, Yamatodani A: Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats. Eur J Pharmacol 2008;578:209-215.
22. 3) of histamine receptor. Nature 1983;302:832-837.
23. 3 receptors in the anaesthetized rat. Naunyn Schmiedebergs Arch Pharmacol 1995;351:569-575.
24. Hough LB: Genomics meets histamine receptors: new subtypes, new receptors. Mol Pharmacol 2001;59:415-419.
25. 3 receptor agonist. J Pharmacol Exp Ther 1992;263:304-310.